Acoustic tumor observation and failure to follow-up.
OBJECTIVE
To review the clinical course of patients undergoing observation for their acoustic tumor with evaluation of the incidence and contributing variables to failure to follow-up.


METHODS
Case series with chart review and telephone interview.


METHODS
Single subspecialty practice.


METHODS
One hundred twenty-two patients underwent an observation period after their unilateral acoustic tumor was diagnosed. Follow-up patterns were noted and multiple patient variables were analyzed to determine risk factors that contributed to risk of failing to keep prescribed follow-up. Telephone interviews and/or public record reviews were conducted to determine the reasons for failing to follow-up.


RESULTS
Fifty-two (42.6%) patients failed to keep prescribed follow-up. No preoperative patient or tumor variables were correlated with the risk of failure to follow-up. The investigators were able to contact and interview 20 patients to determine reasons for not keeping follow-up. Of these patients, nine (45%) electively chose not to follow-up, six (30%) did not appear to have a clear understanding of their diagnosis or treatment options despite adequate counseling, and five (25%) had medical problems that took precedence over the acoustic tumor. Very few patients elected to reschedule follow-up even after contact was made.


CONCLUSIONS
Failure to follow-up is a serious problem with acoustic tumor observation protocols. It is difficult to detect which patients are at risk for noncompliance. Patient noncompliance with observation protocols should be considered when determining the most appropriate treatment for each acoustic tumor patient.
Hillman
Todd A
TA
Pittsburgh Ear Associates, Pittsburgh, PA 15090, USA. todd_hillman@hotmail.com
Chen
Douglas A
DA
Quigley
Matthew
M
Arriaga
Moises A
MA
D000368:Aged; D002985:Clinical Protocols; D003266:Continuity of Patient Care; D006801:Humans; D008297:Male; D008875:Middle Aged; D009464:Neuroma, Acoustic / Q000453:epidemiology / Q000473:pathology / Q000628:therapy*; D010349:Patient Compliance